← FDA Drug Approvals (Drugs@FDA)

CANAGLIFLOZIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS USA INC · Approved 2023-02-13

Drug application

FDA Application #

ANDA210541

Application type

Abbreviated New Drug Application (Generic)

Brand name

CANAGLIFLOZIN

Generic name

Canagliflozin

Active ingredients

CANAGLIFLOZIN

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

ZYDUS PHARMS USA INC

First approval

2023-02-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown